印度印度斯坦实验室将1 410万股的IPO草稿存档,寻找周转资金。 Hindustan Laboratories files IPO draft for 14.1 million shares, seeking funds for working capital.

印度斯坦实验室已向SEBI提交了招股说明书草案，计划IPO发行500万股新股，以及其发起人通过出售要约提供910万股。 Hindustan Laboratories has filed a Draft Red Herring Prospectus with SEBI for an IPO, offering 5 million fresh shares and 9.1 million shares via Offer for Sale by its promoter. 这家向27个州和联邦属地政府机构供应仿制药的制药公司，计划将所得用于营运资金和一般企业用途。 The pharmaceutical company, which supplies generic medicines to government institutions across 27 states and UTs, plans to use proceeds for working capital and general corporate purposes. 首次公开募股由Choice Capital Advisors管理, 目标是在BSE和NSE上市, The IPO, managed by Choice Capital Advisors, aims to list on both BSE and NSE, though pricing and timing remain pending SEBI approval.